ITM2B Chromosome 13
Integral membrane protein 2B
Upload your DNA to see your personal genotypes for variants in ITM2B.
What This Gene Does
Amyloid precursor proteins are processed by beta-secretase and gamma-secretase to produce beta-amyloid peptides which form the characteristic plaques of Alzheimer disease. This gene encodes a transmembrane protein which is processed at the C-terminus by furin or furin-like proteases to produce a small secreted peptide which inhibits the deposition of beta-amyloid. Mutations which result in extension of the C-terminal end of the encoded protein, thereby increasing the size of the secreted peptide, are associated with two neurogenerative diseases, familial British dementia and familial Danish dementia. [provided by RefSeq, Oct 2009]
Gene Info
Gene Group
BRICHOS domain containing
Locus Type
gene with protein product
Location
13q14.2
Ensembl
ENSG00000136156
Associated Conditions (5)
ITM2B-related disorder
Inborn genetic diseases
ABri amyloidosis
ADan amyloidosis
Retinal dystrophy with inner retinal dysfunction and ganglion cell anomalies
Key Variants
RS144217555
Conflicting classifications of pathogenicity
ITM2B-related disorder, ITM2B-related disorder
Health Risk
RS180832133
Conflicting classifications of pathogenicity
Inborn genetic diseases, Inborn genetic diseases
Health Risk
RS201399334
Conflicting classifications of pathogenicity
Inborn genetic diseases, Inborn genetic diseases
Health Risk
RS769773974
Conflicting classifications of pathogenicity
Inborn genetic diseases, ITM2B-related disorder, Inborn genetic diseases
Health Risk
RS2137997888
Likely pathogenic
ABri amyloidosis, ABri amyloidosis
Health Risk
RS104894417
Pathogenic
ABri amyloidosis, ABri amyloidosis
Health Risk
RS606231166
Pathogenic
ADan amyloidosis, ADan amyloidosis
Health Risk
RS606231283
Pathogenic
Retinal dystrophy with inner retinal dysfunction and ganglion cell anomalies, Retinal dystrophy with inner retinal dysfunction and ganglion cell anomalies
Health Risk
All Variants (8)
| RSID | Category | Clinical Significance | Conditions |
|---|---|---|---|
| RS144217555 | Health Risk | Conflicting classifications of pathogenicity | ITM2B-related disorder, ITM2B-related disorder |
| RS180832133 | Health Risk | Conflicting classifications of pathogenicity | Inborn genetic diseases, Inborn genetic diseases |
| RS201399334 | Health Risk | Conflicting classifications of pathogenicity | Inborn genetic diseases, Inborn genetic diseases |
| RS769773974 | Health Risk | Conflicting classifications of pathogenicity | Inborn genetic diseases, ITM2B-related disorder, Inborn genetic diseases |
| RS2137997888 | Health Risk | Likely pathogenic | ABri amyloidosis, ABri amyloidosis |
| RS104894417 | Health Risk | Pathogenic | ABri amyloidosis, ABri amyloidosis |
| RS606231166 | Health Risk | Pathogenic | ADan amyloidosis, ADan amyloidosis |
| RS606231283 | Health Risk | Pathogenic | Retinal dystrophy with inner retinal dysfunction and ganglion cell anomalies, Retinal dystrophy with inner retinal dysfunction and ganglion cell anomalies |